Retrospective Study
Copyright ©The Author(s) 2018.
World J Clin Oncol. Sep 14, 2018; 9(5): 110-118
Published online Sep 14, 2018. doi: 10.5306/wjco.v9.i5.110
Figure 3
Figure 3 Progression-free survival and overall survival according to prior exposure to irinotecan (n = 65). A: Progression-free survival; B: Overall survival.